|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Diovan Tablets, Novartis NDA 020818 3/06/98 8/13/03 Diovan (valsartan) Capsules, Novartis NDA 20-665/S-004 11/27/98 Diovan (valsartan) Capsules & Tablets, Novartis NDA 21-283 7/18/01 5/5/03 8/12/03 Diovan (valsartan) Capsules & Tablets, Novartis NDA 20-665/S-016 & 21-283/S-001 8/14/02 8/21/02 8/14/02 2/3/03 Diovan (valsartan) Tablets, Novartis NDA 21-283/S-002 4/5/02 4/16/02 7/25/02 7/25/02 Diovan HCT (valsartan/hydrochlorothiazide) Tablets, 80/12.5 mg and 160/25 mg Novartis Corp. NDA 20-818/S16 1/15/03 1/23/03 7/8/03 Diovan HCT (valsartan/hydrochlorothiazide) Tablets, 80/12.5 mg and 160/12.5 mg. Novartis Corp. NDA 20-818/S12 Diovan (Valsartan) Tablet, Novartis NDA 21-283 7/18/01 Diovan Indications: Indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. | Diovan (valsartan) Tablets, Novartis Pharma, Labeling Revision | Diovan HCT (valsartan/ hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Diovan HCT (valsartan/ hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Diovan (valsartan) Tablets, Novartis Pharma, New or Modified Indication | Diovan HCT (valsartan hydrochlorothiazide) Tablets, Novartis Pharma, New Dosage Regimen | Diovan (valsartan) Tablets, Novartis Pharma, Labeling Revision | Exforge (amlodipine and valsartan) Tablets, Novartis Pharma, Tentative Approval
|